Gene · 5792
Papers2,345
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,345
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association Between Lactate-to-Albumin Ratio and 28-Day All-Cause Mortality in Critical Care Patients with COPD: Can Both Arterial and Peripheral Venous Lactate Serve as Predictors? | Int J Chron Obstruct Pulmon Dis | 2025 | 40376192 | PubTator, text mining | PubMed |
| Blood urea nitrogen to albumin ratio as predictor of mortality among acute pancreatitis patients in ICU: A retrospective cohort study. | PLoS One | 2025 | 40373080 | PubTator, text mining | PubMed |
| Açaí residue extract as a natural antioxidant to enhance the shelf-life of beef patties. | J Sci Food Agric | 2025 | 40351263 | PubTator, text mining | PubMed |
| Lactate dehydrogenase to albumin ratio as an independent factor for 28-day mortality of neonatal sepsis. | Sci Rep | 2025 | 40307261 | PubTator, text mining | PubMed |
| Statement of Retraction: miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F. | Bioengineered | 2025 | 40267101 | PubTator, text mining | PubMed |
| Surrogate molecular classification of LAR breast cancer in routine workflow. | Endocr Relat Cancer | 2025 | 40265610 | PubTator, text mining | PubMed |
| APOBEC-Driven Hypermutation in the Lymphocyte-Predominant Group of Triple-Negative Breast Cancer. | Lab Invest | 2025 | 40199422 | PubTator, text mining | PubMed |
| Expanding ligand-receptor interaction networks for axon guidance: Structural insights into signal crosstalk and specificity. | Curr Opin Neurobiol | 2025 | 40117944 | PubTator, text mining | PubMed |
| Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers. | BMC Cancer | 2025 | 40082760 | PubTator, text mining | PubMed |
| Population-specific patterns in assessing molecular subtypes of young black females with triple-negative breast cancer. | NPJ Breast Cancer | 2025 | 40069179 | PubTator, text mining | PubMed |
| Prognostic Significance and Molecular Classification of Triple Negative Breast Cancer: A Systematic Review. | Eur J Breast Health | 2025 | 40028895 | PubTator, text mining | PubMed |
| Unraveling ADHD: genes, co-occurring traits, and developmental dynamics. | Life Sci Alliance | 2025 | 40000109 | PubTator, text mining | PubMed |
| Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial. | Lancet Oncol | 2025 | 39978376 | PubTator, text mining | PubMed |
Establishment and validation of predictive models by mutational and transcriptional factors for the prognosis of stage IV colorectal cancer patients with liver metastasis who undergo palliative surgery on primary tumors. | Transl Cancer Res | 2025 | 39974400 | PubTator, text mining | PubMed |
| Classification of Breast Cancer Through the Perspective of Cell Identity Models. | Adv Exp Med Biol | 2025 | 39821027 | PubTator, text mining | PubMed |
| The binuclear cyclopalladated complex CP2 is targeting ubiquinol-cytochrome c reductase (complex III) of Leishmania amazonensis. | Int J Parasitol Drugs Drug Resist | 2025 | 39746288 | PubTator, text mining | PubMed |
| Protein-free catalysis of DNA hydrolysis and self-integration by a ribozyme. | Nucleic Acids Res | 2025 | 39698822 | PubTator, text mining | PubMed |
| Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis. | Mol Cancer Ther | 2025 | 39588561 | PubTator, text mining | PubMed |
| Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities. | Med Res Rev | 2025 | 39445844 | PubTator, text mining | PubMed |
| Why the adventitious roots of poplar are so colorful: RNAseq and metabolomic analysis reveal anthocyanin accumulation in canker pathogens-induced adventitious roots in poplar. | Planta | 2024 | 39694940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5792/papers?page=6